This systematic review highlighted the potential of plant extracts and compounds in inhibiting HSP90 activity and inducing anticancer effects in breast cancer models through a rigorous search strategy adhering to PRISMA 2020 guidelines. Here, HSP90AA1 is linked to breast cancer.